Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
In 2026, a trio of regulated utilities stands out for investors chasing steady cash flow and dividend growth amid rat...
STRC slid to a deep intraday low near $82.61 on June 18 before rebounding, signaling distress in the Bitcoin-linked d...
Medicare's day-count cliffs push hospital costs $434 per day after day 60, rising to $868 per day after day 90. The p...
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
A couple’s big casino win two years ago triggered higher Medicare premiums today, underscoring how IRMAA rules can su...
HUD unveils 14 policy updates to the FHA single-family program, designed to cut red tape, reduce costs, and broaden a...
Global markets are buzzing as offshore crypto platforms increasingly offer pre-IPO exposure tied to SpaceX rumors. Tr...
AI-driven memory demand pushes prices higher, prompting Apple to raise Mac and iPad prices by roughly 20%. The indust...
CFOs are bullish about their own firms even as the broader economy slows, according to Deloitte's Q2 2026 CFO Signals...
A major milestone sits on the horizon: Securitize, with BlackRock backing, is preparing to trade as a tokenized secur...
A high-earning retiree with a $90,000 pension and a $1.5 million pre-tax IRA faces a tax barrier that makes Roth conv...